トップ > 製品検索結果一覧
| クリップ | Code No. | 品名 | データ | ||||
|---|---|---|---|---|---|---|---|
| データ
シート |
項目 | 標識 | MHC Allele | 包装 | 価格 | 在庫 | |
| 配列 | 位置 | 温度 | |||||
|
|
|||||||
|
TB-0157-1 |
HLA-A*02:01 p53 Tetramer-RMPEAAPPV-PE |
|
||||
| cancer | PE | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| RMPEAAPPV | 65-73 | 4°C | |||||
|
|
TB-0159-2 |
HLA-A*02:01 p53 Tetramer-SLPPPGTRV-APC |
|
||||
| cancer | APC | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| SLPPPGTRV | 149-157 | 4°C | |||||
|
|
TB-0159-4 |
HLA-A*02:01 p53 Tetramer-SLPPPGTRV-BV421 |
|
||||
| cancer | BV421 | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| SLPPPGTRV | 149-157 | 4°C | |||||
|
|
TB-0159-1 |
HLA-A*02:01 p53 Tetramer-SLPPPGTRV-PE |
|
||||
| cancer | PE | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| SLPPPGTRV | 149-157 | 4°C | |||||
|
|
TB-0163-2 |
HLA-A*02:01 p53 Tetramer-YLGSYGFRL-APC |
|
||||
| cancer | APC | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| YLGSYGFRL | 103-111 | 4°C | |||||
|
|
TB-0163-4 |
HLA-A*02:01 p53 Tetramer-YLGSYGFRL-BV421 |
|
||||
| cancer | BV421 | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| YLGSYGFRL | 103-111 | 4°C | |||||
|
|
TB-0163-1 |
HLA-A*02:01 p53 Tetramer-YLGSYGFRL-PE |
|
||||
| cancer | PE | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| YLGSYGFRL | 103-111 | 4°C | |||||
|
|
TB-M120-1 |
HLA-A*02:01 PSA 141-150 Tetramer-FLTPKKLQCV-PE
|
|
||||
| cancer | PE | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| FLTPKKLQCV | 141-150 | 4°C | |||||
|
|
TB-0127-2 |
HLA-A*02:01 PSCA Tetramer-AILALLPAL-APC |
|
||||
| cancer | APC | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| AILALLPAL | 105-133 | 4°C | |||||
|
|
TB-0127-4 |
HLA-A*02:01 PSCA Tetramer-AILALLPAL-BV421 |
|
||||
| cancer | BV421 | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| AILALLPAL | 105-133 | 4°C | |||||
|
|
TB-0127-1 |
HLA-A*02:01 PSCA Tetramer-AILALLPAL-PE |
|
||||
| cancer | PE | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| AILALLPAL | 105-133 | 4°C | |||||
|
|
TB-0161-2 |
HLA-A*02:01 PSMA Tetramer-VLAGGFFLL-APC |
|
||||
| cancer | APC | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| VLAGGFFLL | 27-38 | 4°C | |||||
|
|
TB-0161-4 |
HLA-A*02:01 PSMA Tetramer-VLAGGFFLL-BV421 |
|
||||
| cancer | BV421 | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| VLAGGFFLL | 27-38 | 4°C | |||||
|
|
TB-0161-1 |
HLA-A*02:01 PSMA Tetramer-VLAGGFFLL-PE |
|
||||
| cancer | PE | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| VLAGGFFLL | 27-38 | 4°C | |||||
|
|
TB-0132-2 |
HLA-A*02:01 topo II Tetramer-FLYDDNQRV-APC |
|
||||
| cancer | APC | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| FLYDDNQRV | 828-836 | 4°C | |||||
|
|
TB-0132-4 |
HLA-A*02:01 topo II Tetramer-FLYDDNQRV-BV421 |
|
||||
| cancer | BV421 | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| FLYDDNQRV | 828-836 | 4°C | |||||
|
|
TB-0132-1 |
HLA-A*02:01 topo II Tetramer-FLYDDNQRV-PE |
|
||||
| cancer | PE | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| FLYDDNQRV | 828-836 | 4°C | |||||
|
|
TB-0138-2 |
HLA-A*03:01 HIV Nef Tetramer-QVPLRPMTYK-APC |
|
||||
|
virus HIV |
APC | A*03:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| QVPLRPMTYK | 73-82 | 4°C | |||||
|
|
TB-0138-4 |
HLA-A*03:01 HIV Nef Tetramer-QVPLRPMTYK-BV421 |
|
||||
|
virus HIV |
BV421 | A*03:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| QVPLRPMTYK | 73-82 | 4°C | |||||
|
|
TB-0138-1 |
HLA-A*03:01 HIV Nef Tetramer-QVPLRPMTYK-PE |
|
||||
|
virus HIV |
PE | A*03:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| QVPLRPMTYK | 73-82 | 4°C | |||||
|
|
TB-0137-2 |
HLA-A*03:01 HPV E6 Tetramer-KLCLRFLSK-APC |
|
||||
|
virus HPV |
APC | A*03:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| KLCLRFLSK | 64-72 | 4°C | |||||
|
|
TB-0137-4 |
HLA-A*03:01 HPV E6 Tetramer-KLCLRFLSK-BV421 |
|
||||
|
virus HPV |
BV421 | A*03:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| KLCLRFLSK | 64-72 | 4°C | |||||
|
|
TB-0137-1 |
HLA-A*03:01 HPV E6 Tetramer-KLCLRFLSK-PE |
|
||||
|
virus HPV |
PE | A*03:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| KLCLRFLSK | 64-72 | 4°C | |||||
|
|
TS-M152-2 |
HLA-A*11:01 Control Tetramer-ATAAAAAAK-APC |
|
||||
|
negative | APC | A*11:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| ATAAAAAAK | 4°C | ||||||
|
|
TS-M152-3 |
HLA-A*11:01 Control Tetramer-ATAAAAAAK-FITC |
|
||||
|
|
negative | FITC | A*11:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| ATAAAAAAK | 4°C | ||||||
|
|
TS-M152-1 |
HLA-A*11:01 Control Tetramer-ATAAAAAAK-PE |
|
||||
|
|
negative | PE | A*11:01 | 50 tests | ￥209,000 | 1-9 | |
| ATAAAAAAK | 4°C | ||||||
|
|
TS-M153-2 |
HLA-A*24:02 Control Tetramer-AYAAAAAAL-APC |
|
||||
|
|
negative | APC | A*24:02 | 50 tests | ￥209,000 | 1-9 | |
| AYAAAAAAL | 4°C | ||||||
|
|
TS-M153-3 |
HLA-A*24:02 Control Tetramer-AYAAAAAAL-FITC |
|
||||
|
|
negative | FITC | A*24:02 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| AYAAAAAAL | 4°C | ||||||
|
|
TS-M153-1 |
HLA-A*24:02 Control Tetramer-AYAAAAAAL-PE |
|
||||
|
|
negative | PE | A*24:02 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| AYAAAAAAL | 4°C | ||||||
|
|
TS-M001-2 |
HLA-A*24:02 EBV LMP2 Tetramer-IYVLVMLVL-APC |
|
||||
|
|
virus | APC | A*24:02 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| IYVLVMLVL | 222-230 | 4°C | |||||
|
|
TS-M154-2 |
HLA-A*24:02 EBV LMP2 Tetramer-TYGPVFMCL-APC |
|
||||
|
|
virus | APC | A*24:02 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| TYGPVFMCL | 419-427 | 4°C | |||||
|
|
TS-M154-1 |
HLA-A*24:02 EBV LMP2 Tetramer-TYGPVFMCL-PE |
|
||||
|
|
virus | PE | A*24:02 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| TYGPVFMCL | 419-427 | 4°C | |||||
|
|
TB-0140-2 |
HLA-A*24:02 GPC3 Tetramer-EYILSLEEL-APC |
|
||||
| cancer | APC | A*24:02 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| EYILSLEEL | 298-306 | 4°C | |||||
|
|
TB-0140-4 |
HLA-A*24:02 GPC3 Tetramer-EYILSLEEL-BV421 |
|
||||
| cancer | BV421 | A*24:02 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| EYILSLEEL | 298-306 | 4°C | |||||
|
|
TB-0140-1 |
HLA-A*24:02 GPC3 Tetramer-EYILSLEEL-PE |
|
||||
| cancer | PE | A*24:02 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| EYILSLEEL | 298-306 | 4°C | |||||
|
|
TB-0130-2 |
HLA-A*24:02 HIV env Tetramer-RYLKDQQLL-APC |
|
||||
|
virus HIV |
APC | A*24:02 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| RYLKDQQLL | 67-75 | 4°C | |||||
|
|
TB-0130-4 |
HLA-A*24:02 HIV env Tetramer-RYLKDQQLL-BV421 |
|
||||
|
virus HIV |
BV421 | A*24:02 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| RYLKDQQLL | 67-75 | 4°C | |||||
|
|
TB-0130-1 |
HLA-A*24:02 HIV env Tetramer-RYLKDQQLL-PE |
|
||||
|
virus HIV |
PE | A*24:02 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| RYLKDQQLL | 67-75 | 4°C | |||||
|
|
TB-0167-2 |
HLA-A*24:02 LY6K Tetramer-RYCNLEGPPI-APC |
|
||||
| cancer | APC | A*24:02 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| RYCNLEGPPI | 177-186 | 4°C | |||||
|
|
TB-0167-4 |
HLA-A*24:02 LY6K Tetramer-RYCNLEGPPI-BV421 |
|
||||
| cancer | BV421 | A*24:02 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| RYCNLEGPPI | 177-186 | 4°C | |||||
|
|
TB-0167-1 |
HLA-A*24:02 LY6K Tetramer-RYCNLEGPPI-PE |
|
||||
| cancer | PE | A*24:02 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| RYCNLEGPPI | 177-186 | 4°C | |||||
|
|
TB-0139-2 |
HLA-A*24:02 PSA Tetramer-CYASGWGSI-APC |
|
||||
| cancer | APC | A*24:02 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| CYASGWGSI | 153-161 | 4°C | |||||
|
|
TB-0139-4 |
HLA-A*24:02 PSA Tetramer-CYASGWGSI-BV421 |
|
||||
| cancer | BV421 | A*24:02 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| CYASGWGSI | 153-161 | 4°C | |||||
|
|
TB-0139-1 |
HLA-A*24:02 PSA Tetramer-CYASGWGSI-PE |
|
||||
| cancer | PE | A*24:02 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| CYASGWGSI | 153-161 | 4°C | |||||
|
|
TS-M137-2 |
HLA-A*01:01 AIM-2 Tetramer-RSDSGQQARY-APC |
|
||||
|
|
cancer | APC | A*01:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| RSDSGQQARY | - | 4°C | |||||
|
|
TS-M137-1 |
HLA-A*01:01 AIM-2 Tetramer-RSDSGQQARY-PE |
|
||||
|
|
cancer | PE | A*01:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| RSDSGQQARY | - | 4°C | |||||
|
|
TB-0125-2 |
HLA-A*01:01 HCV polyprotein Tetramer-ATDALMTGY-APC |
|
||||
|
virus HCV |
APC | A*01:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| ATDALMTGY | 4°C | ||||||
|
|
TB-0125-4 |
HLA-A*01:01 HCV polyprotein Tetramer-ATDALMTGY-BV421 |
|
||||
|
virus HCV |
BV421 | A*01:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| ATDALMTGY | 4°C | ||||||
|
|
TB-0125-1 |
HLA-A*01:01 HCV polyprotein Tetramer-ATDALMTGY-PE |
|
||||
|
virus HCV |
PE | A*01:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| ATDALMTGY | 4°C | ||||||
|
|
TS-M114-2 |
HLA-A*01:01 MAGE-A1 Tetramer-EADPTGHSY-APC |
|
||||
|
|
cancer | APC | A*01:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| EADPTGHSY | 161-169 | 4°C | |||||
|
|
TS-M114-1 |
HLA-A*01:01 MAGE-A1 Tetramer-EADPTGHSY-PE |
|
||||
|
|
cancer | PE | A*01:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| EADPTGHSY | 161-169 | 4°C | |||||
|
|
TB-M074-4 |
HLA-A*01:01 MAGE-A3 Tetramer-EVDPIGHLY-BV421 |
|
||||
| cancer | BV421 | A*01:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| EVDPIGHLY | 168-176 | 4°C | |||||
|
|
TS-M058-2 |
HLA-A*02:01 Adenovirus 11 Hexon913-921 Tetramer-YLLFEVFDV-APC |
|
||||
|
|
virus | APC | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| YLLFEVFDV | 913-921 | 4°C | |||||
|
|
TS-M058-1 |
HLA-A*02:01 Adenovirus 11 Hexon913-921 Tetramer-YLLFEVFDV-PE |
|
||||
|
|
virus | PE | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| YLLFEVFDV | 913-921 | 4°C | |||||
|
|
TB-M059-2 |
HLA-A*02:01 Adenovirus 11 Hexon914-922 Tetramer-LLFEVFDVV-APC |
|
||||
|
virus AdV |
APC | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| LLFEVFDVV | 914-922 | 4°C | |||||
|
|
TB-M059-1 |
HLA-A*02:01 Adenovirus 11 Hexon914-922 Tetramer-LLFEVFDVV-PE |
|
||||
|
virus AdV |
PE | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| LLFEVFDVV | 914-922 | 4°C | |||||
|
|
TS-M097-2 |
HLA-A*02:01 BTG1 Tetramer-TLWVDPYEV-APC |
|
||||
|
|
Others | APC | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| TLWVDPYEV | 103-111 | 4°C | |||||
|
|
TS-M097-1 |
HLA-A*02:01 BTG1 Tetramer-TLWVDPYEV-PE |
|
||||
|
|
Others | PE | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| TLWVDPYEV | 103-111 | 4°C | |||||
|
|
TS-M102-2 |
HLA-A*02:01 CD33 A65Y Tetramer-YIISGDSPV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| YIISGDSPV | 65-73 | 4°C | |||||
|
|
TS-M102-1 |
HLA-A*02:01 CD33 A65Y Tetramer-YIISGDSPV-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| YIISGDSPV | 65-73 | 4°C | |||||
|
|
TS-M101-2 |
HLA-A*02:01 CD33 Tetramer-AIISGDSPV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| AIISGDSPV | 65-73 | 4°C | |||||
|
|
TS-M101-1 |
HLA-A*02:01 CD33 Tetramer-AIISGDSPV-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| AIISGDSPV | 65-73 | 4°C | |||||
|
|
TS-M080-2 |
HLA-A*02:01 CEA (N6D) Tetramer-YLSGADLNL-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| YLSGADLNL | 605-613 | 4°C | |||||
|
|
TS-M080-1 |
HLA-A*02:01 CEA (N6D) Tetramer-YLSGADLNL-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| YLSGADLNL | 605-613 | 4°C | |||||
|
|
TS-M103-2 |
HLA-A*02:01 CEA Tetramer-YLSGANLNL-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| YLSGANLNL | 605-613 | 4°C | |||||
|
|
TS-M103-1 |
HLA-A*02:01 CEA Tetramer-YLSGANLNL-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 | 1-9 | |
| YLSGANLNL | 605-613 | 4°C | |||||
|
|
TB-M057-1 |
HLA-A*02:01 CMV IE1 316-324 Tetramer-VLEETSVML-PE |
|
||||
| virus | PE | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| VLEETSVML | 316-324 | 4°C | |||||
|
|
TB-M057-2 |
HLA-A*02:01 CMV IE1316-324 Tetramer-VLEETSVML-APC |
|
||||
|
virus CMV |
APC | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| VLEETSVML | 316-324 | 4°C | |||||
|
|
TS-M032-2 |
HLA-A*02:01 EBV LMP2 Tetramer-CLGGLLTMV-APC |
|
||||
|
|
virus EBV |
APC | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| CLGGLLTMV | 426-434 | 4°C | |||||
|
|
TS-M032-1 |
HLA-A*02:01 EBV LMP2 Tetramer-CLGGLLTMV-PE |
|
||||
|
|
virus EBV |
PE | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| CLGGLLTMV | 426-434 | 4°C | |||||
|
|
TS-M069-2 |
HLA-A*02:01 EBV LMP2 Tetramer-FLYALALLL-APC |
|
||||
|
|
virus EBV |
APC | A*02:01 | 50 tests | ￥209,000 | 1-9 | |
| FLYALALLL | 356-364 | 4°C | |||||
|
|
TS-M069-1 |
HLA-A*02:01 EBV LMP2 Tetramer-FLYALALLL-PE |
|
||||
|
|
virus EBV |
PE | A*02:01 | 50 tests | ￥209,000 | 1-9 | |
| FLYALALLL | 356-364 | 4°C | |||||
|
|
TS-M031-2 |
HLA-A*02:01 EBV LMP2 Tetramer-LLWTLVVLL-APC |
|
||||
|
|
virus EBV |
APC | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| LLWTLVVLL | 329-337 | 4°C | |||||
|
|
TS-M031-1 |
HLA-A*02:01 EBV LMP2 Tetramer-LLWTLVVLL-PE |
|
||||
|
|
virus EBV |
PE | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| LLWTLVVLL | 329-337 | 4°C | |||||
|
|
TS-M030-2 |
HLA-A*02:01 EBV LMP2 Tetramer-TVCGGIMFL-APC |
|
||||
|
|
virus EBV |
APC | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| TVCGGIMFL | 243-251 | 4°C | |||||
|
|
TS-M030-1 |
HLA-A*02:01 EBV LMP2 Tetramer-TVCGGIMFL-PE |
|
||||
|
|
virus EBV |
PE | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| TVCGGIMFL | 243-251 | 4°C | |||||
|
|
TS-M084-2 |
HLA-A*02:01 EphA2 Tetramer-TLADFDPRV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| TLADFDPRV | 883-891 | 4°C | |||||
|
|
TS-M084-1 |
HLA-A*02:01 EphA2 Tetramer-TLADFDPRV-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| TLADFDPRV | 883-891 | 4°C | |||||
|
|
TB-M082-2 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTA-APC |
|
||||
| cancer | APC | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| YLEPGPVTA | 280-288 | 4°C | |||||
|
|
TB-M082-1 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTA-PE |
|
||||
| cancer | PE | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| YLEPGPVTA | 280-288 | 4°C | |||||
|
|
TB-0120-2 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTV-APC |
|
||||
| cancer | APC | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| YLEPGPVTV | 4°C | ||||||
|
|
TB-0120-4 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTV-BV421 |
|
||||
| cancer | BV421 | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| YLEPGPVTV | 4°C | ||||||
|
|
TB-0120-1 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTV-PE |
|
||||
| cancer | PE | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| YLEPGPVTV | 4°C | ||||||
|
|
TS-M094-2 |
HLA-A*02:01 H-Y Tetramer-FIDSYICQV-APC |
|
||||
|
|
Others | APC | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| FIDSYICQV | 311-319 | 4°C | |||||
|
|
TS-M094-1 |
HLA-A*02:01 H-Y Tetramer-FIDSYICQV-PE |
|
||||
|
|
Others | PE | A*02:01 | 50 tests | ￥209,000 | 1-9 | |
| FIDSYICQV | 311-319 | 4°C | |||||
|
|
TS-M093-2 |
HLA-A*02:01 HA-1 Tetramer-VLHDDLLEA-APC |
|
||||
|
|
Others | APC | A*02:01 | 50 tests | ￥209,000 | 1-9 | |
| VLHDDLLEA | 137-145 | 4°C | |||||
|
|
TS-M093-1 |
HLA-A*02:01 HA-1 Tetramer-VLHDDLLEA-PE |
|
||||
|
|
Others | PE | A*02:01 | 50 tests | ￥209,000 | 1-9 | |
| VLHDDLLEA | 137-145 | 4°C | |||||
|
|
TS-M108-2 |
HLA-A*02:01 HA-2 Tetramer-YIGEVLVSV-APC |
|
||||
|
|
Others | APC | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| YIGEVLVSV | 41-49 | 4°C | |||||
|
|
TS-M108-1 |
HLA-A*02:01 HA-2 Tetramer-YIGEVLVSV-PE |
|
||||
|
|
Others | PE | A*02:01 | 50 tests | ￥209,000 | 1-9 | |
| YIGEVLVSV | 41-49 | 4°C | |||||
|
|
TS-M098-2 |
HLA-A*02:01 HA-8 Tetramer-RTLDKVLEV-APC |
|
||||
|
|
Others | APC | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| RTLDKVLEV | 149-157 | 4°C | |||||
|
|
TS-M098-1 |
HLA-A*02:01 HA-8 Tetramer-RTLDKVLEV-PE |
|
||||
|
|
Others | PE | A*02:01 | 50 tests | ￥209,000 | 1-9 | |
| RTLDKVLEV | 149-157 | 4°C | |||||
|
|
TB-M051-2 |
HLA-A*02:01 HBV env 335-343 Tetramer-WLSLLVPFV-APC |
|
||||
| virus | APC | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| WLSLLVPFV | 335-343 | 4°C | |||||
|
|
TB-M051-1 |
HLA-A*02:01 HBV env 335-343 Tetramer-WLSLLVPFV-PE |
|
||||
| virus | PE | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| WLSLLVPFV | 335-343 | 4°C | |||||
|
|
TS-M052-2 |
HLA-A*02:01 HBV env 348-357 Tetramer-GLSPTVWLSV-APC |
|
||||
|
|
virus | APC | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| GLSPTVWLSV | 348-357 | 4°C | |||||
|
|
TS-M052-1 |
HLA-A*02:01 HBV env 348-357 Tetramer-GLSPTVWLSV-PE |
|
||||
|
|
virus | PE | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| GLSPTVWLSV | 348-357 | 4°C | |||||
|
|
TB-0122-2 |
HLA-A*02:01 HBV S protein Tetramer-FLLTRILTI-APC |
|
||||
|
virus HBV |
APC | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| FLLTRILTI | 4°C | ||||||
|
|
TB-0122-4 |
HLA-A*02:01 HBV S protein Tetramer-FLLTRILTI-BV421 |
|
||||
|
virus HBV |
BV421 | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| FLLTRILTI | 4°C | ||||||
|
|
TB-0122-1 |
HLA-A*02:01 HBV S protein Tetramer-FLLTRILTI-PE |
|
||||
|
virus HBV |
PE | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| FLLTRILTI | 4°C | ||||||
|
|
TB-0118-2 |
HLA-A*02:01 HCV NS3 1073-1081 Tetramer CVNGVCWTV-APC |
|
||||
|
virus HCV |
APC | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| CVNGVCWTV | 4°C | ||||||
|
|
TB-M039-4 |
HLA-A*02:01 HCV NS3 1073-1081 Tetramer-CINGVCWTV-BV421 |
|
||||
|
virus HCV |
BV421 | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| CINGVCWTV | 1073-1081 | 4°C | |||||
※在庫につきましては2024年05月20日 17時00分時点における在庫数を表示してあります。
※価格の赤色表示につきましては、
キャンペーン価格の表示となっております。
※このサイトからは直接注文はできません。ご注意ください。
※保存温度の表記について： RT: 室温
※本サイトの掲載製品は、品質改良のため予告なく仕様などの変更、または販売中止となる場合がございます。あらかじめご了承ください。